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Infectious Diseases and Mental Illness:
Is There a Link?
To the Editor: The report by Hatalski et al. (1) on
Borna virus as a probable human pathogen
provides yet another example of an infectious agent
being tentatively associated with neuropsychiatric
disorders.  Earlier this year, researchers at
Rockefeller University and the National Institute
of Mental Health suggested that after streptococ-
cal infection, some children may be at increased
risk for obsessive-compulsive disorders and
Tourette syndrome (2). The human B-cell antigen
D8/17, believed to be a marker for increased
susceptibility to poststreptococcal rheumatic
heart disease, has been tentatively linked to this
increased risk for psychiatric illness in children.
Other reports of patients with complicated Lyme
borreliosis, including some whose infections have
progressed to encephalopathies, describe persis-
tent verbal and memory deficits among these
patients (3). In a few Lyme disease patients, the
only overt symptoms of disease at the time of
initial diagnosis and treatment were classified as
mental confusion (4). Two newly emergent
infectious diseases in the United States, leptospiro-
sis and neurocysticercosis, have been found among
inner city residents and poor immigrants,
respectively. Occasionally leptospirosis has been
associated with a variety of postinfectious
psychiatric symptoms, including depression,
dementia, and psychosis (5). Neurocysticercosis,
a tropical parasitic infection, is increasingly
associated with emergency room admissions for
seizures and epilepsy (6). Still other infectious
diseases are being examined for links with
cognitive symptoms and emotional disorders.
The primary cause of many common
psychiatric disorders, including depression,
manic depression, anxiety, and schizophrenia,
remains a mystery. The World Health Organiza-
tion estimates that 1.5 billion people worldwide
suffer from a neuropsychiatric disorder. Of the 10
leading causes of disability in 1990, four were
psychiatric disorders: unipolar depression, manic
depression, schizophrenia, and obsessive-com-
pulsive disorders (7). The National Institute of
Mental Health recently estimated that as many
as 20% of young Americans ages 7 to 14—
approximately 10 million children—have mental
health problems severe enough to compromise
their ability to function (8). Infectious agents may
play a role in some of these diseases to some
unknown degree. A better understanding of the role
of infection may speed treatment and prevention
efforts and reduce the degree of disability and
stigma associated with mental illness.
Vaccines and antimicrobial agents might
enhance current therapeutic options for mental
illnesses. Even if infectious diseases were a
primary factor in only 1% of neuropsychiatric
illnesses, some 10 million persons might benefit
from antimicrobial therapies. Identifying those
susceptible to neuropsychiatric illnesses (be-
cause of environmental factors or genetic
predisposition) may also permit vaccination or
antimicrobial prophylaxis and a subsequent
lowering of disease incidence.
Physicians and federal agencies addressing
the problems of emerging infectious diseases
should examine the possibility of infection as a
cause of mental illness. Better communication
among infectious disease and mental health
experts, as well as additional training, will be
needed to shed light on the growing phenomenon
of infectious diseases manifesting themselves as
neuropsychiatric disorders.
Edward McSweegan
National Institute of Allergy and Infectious
Diseases, Bethesda, Maryland, USA
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Mycobacterium nonchromogenicum
Bacteremia in an AIDS Patient
To the Editor: Mycobacterium avium complex is
the most common nontuberculous mycobacterium
that causes disseminated infection in HIV-
positive patients (1). Other less common
nontuberculous mycobacteria responsible for
disseminated disease in these patients are M.
fortuitum (2), M. genavense (3), M. gordonae (4),
M. haemophilum (5), M. kansasii (6), M.
malmoense (7), M. marinum (8), M. scrofulaceum
(9), M. simiae (10), M. szulgai (11), M. terrae (9),
and M. xenopi (2,9). Although only M. genavense,
M. kansasii, and M. xenopi are significantly more
frequent in these patients (2,3,9), HIV infection is
likely a predisposing condition for all
nontuberculous mycobacterial infections. We
report the first case of disseminated infection
caused by M. nonchromogenicum in an HIV-
infected patient.
A 28-year-old man with HIV infection
acquired by sharing injection tools was seen in
our outpatient clinic because of intermittent
fever, drenching nocturnal sweats, and cough
with purulent sputum of 4 months’ duration. He
also reported a weight loss of 10 kg in the
previous 2 months. He had been diagnosed with
bronchial infection in another hospital and had
been treated with an unknown antibiotic. After
this treatment, respiratory symptoms had
improved somewhat, but fever and constitutional
symptoms continued. His only previous opportu-
nistic infection had been recurrent oral and
esophageal candidiasis. The last CD4-cell count
had been 16/mL 1 year earlier, and he was
receiving didanosine and prophylactic therapy
with cotrimoxazole and fluconazole. On physical
examination the patient appeared ill; he was
febrile, cachectic, and had thrush and oral hairy
leukoplakia. Neither lymphadenopathy nor
abnormal cardiopulmonary symptoms were
found. The liver, which had enlarged since the
last examination, was palpated 6 cm below the
right costal margin. Abnormal laboratory values
included aspartate aminotransferase 61 U/L,
gamma-glutamyl transferase 209 U/L, lactate
dehydrogenase 516 U/L, hemoglobin 12.3 g/dL,
leukocyte count 4,300/mL (66% neutrophils, 19%
band forms, 1% metamyelocytes, 3% lympho-
cytes, 11% monocytes), platelet count 130,000/mL,
and erythrocyte sedimentation rate 72 mm/h.
Chest X-rays were unremarkable, and a set of
blood cultures was sterile. A sputum culture
yielded Haemophilus influenzae sensitive to
ampicillin, and smears and cultures for mycobac-
teria in one stool and three sputum samples were
negative.
The patient was treated with oral amoxicillin
for 2 weeks without improvement. Empirical
therapy against M. avium complex with
clarithromycin, ciprofloxacin, and ethambutol
was started; the patient’s condition improved
dramatically within the next few days, and the
fever and diaphoresis disappeared, although
cough and sputum production remained un-
changed. Three weeks later, a slow-growing
nonphotochromogenic mycobacterium, identified
as  M. nonchromogenicum in a reference
laboratory (Centro Nacional de Microbiología,
Majadahonda, Madrid, Spain) by biochemical
tests and confirmed by polymerase chain
reaction-restriction enzyme pattern analysis,
was isolated from a blood sample obtained on
admission. This microorganism was sensitive to
the three drugs administered, and the treatment
was continued. Two months later the patient had
gained 10 kg, hemoglobin had increased to 13.8
g/dL, the erythrocyte sedimentation rate had
decreased to 52 mm/h, and the differential
leukocyte count had returned to normal.
Antimycobacterial drugs were withheld after 1
year of treatment. Twenty-two months after the
diagnosis, the patient is doing well. He is
receiving combination antiretroviral therapy,
and his CD4-cell count is 128/mL.
M. nonchromogenicum, a slow-growing non-
pigmented (Runyon’s group III) mycobacterium,
belongs to the M. terrae complex, together with
M. triviale; it is traditionally considered
nonpathogenic. However, it has been involved in
a few cases of pulmonary infection (12) and
chronic tenosynovitis secondary to puncture
wounds (13), like the related organism M. terrae.
In fact, some authors think that M.
nonchromogenicum is the true pathogen in the
M. terrae complex (13), and it is possible that
some reports have misidentified this organism.
This complex was first isolated in soil washings